CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 62 filers reported holding CYTOSORBENTS CORP in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $15,304 | -48.2% | 4,263 | -51.4% | 0.00% | – |
Q1 2023 | $29,531 | +105367.9% | 8,763 | +48583.3% | 0.00% | – |
Q4 2022 | $28 | -98.6% | 18 | -98.9% | 0.00% | – |
Q3 2022 | $2,000 | -50.0% | 1,654 | 0.0% | 0.00% | – |
Q2 2022 | $4,000 | -69.2% | 1,654 | 0.0% | 0.00% | – |
Q3 2021 | $13,000 | -74.5% | 1,654 | -75.1% | 0.00% | – |
Q1 2020 | $51,000 | +2450.0% | 6,648 | +1595.9% | 0.00% | – |
Q3 2019 | $2,000 | +100.0% | 392 | +326.1% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 92 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | -97.4% | 92 | -98.0% | 0.00% | – |
Q4 2018 | $38,000 | -40.6% | 4,664 | -6.6% | 0.00% | -100.0% |
Q3 2018 | $64,000 | -45.3% | 4,991 | -51.2% | 0.00% | 0.0% |
Q2 2018 | $117,000 | +5750.0% | 10,221 | +3924.0% | 0.00% | – |
Q3 2017 | $2,000 | -89.5% | 254 | -94.3% | 0.00% | – |
Q2 2017 | $19,000 | -34.5% | 4,454 | -29.9% | 0.00% | – |
Q1 2017 | $29,000 | +314.3% | 6,354 | +369.3% | 0.00% | – |
Q4 2016 | $7,000 | -12.5% | 1,354 | +8.0% | 0.00% | – |
Q3 2016 | $8,000 | – | 1,254 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |